Hemangioma
A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
Subtype terms (6)
More specific conditions that are subtypes of Hemangioma in the MeSH hierarchy.
- Central Nervous System Venous Angioma
- Hemangioendothelioma
9 drugs (7 approved, 2 experimental)
- Hemangioma, Capillary
2 drugs approved
- Hemangioma, Cavernous
- Kasabach-Merritt Syndrome
3 drugs approved
- Sturge-Weber Syndrome
5 drugs (4 approved, 1 experimental)
Drugs by status
Phase 4 trials (7)
Phase 3 trials (4)
Phase 2 trials (2)
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (22)
- Bausch Health Companies
- Pfizer
- Graceway
- The EMMES Corporation
- University of Pennsylvania
- Augusta University
- Harvard University
- Duke University
- University of Washington
- Medical College of Wisconsin
- Capital Medical University
- University of California, San Diego
- Zhejiang University
- Food and Drug Administration
- University of Lyon
- University of Montreal
- University of Sao Paulo
- University of Barcelona
- University of Massachusetts
- Department of Veteran Affairs
- Children's National Medical Center
- University of Picardie Jules Verne
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (5)